Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 2/3 1Phase 2 1

Status

Withdrawn 1Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 5

Conditions

Lymphoma 539Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Lymphoma, Non-Hodgkin 435Lymphoma, Follicular 403Leukemia, Lymphocytic, Chronic, B-Cell 388Lymphoma, Large B-Cell, Diffuse 385Lymphoma, B-Cell 246Lymphoma, Mantle-Cell 222Hodgkin Disease 207Recurrence 204Leukemia, Myeloid, Acute 197Leukemia 191Multiple Myeloma 184Burkitt Lymphoma 181Lymphoma, B-Cell, Marginal Zone 170Neoplasms 151Myelodysplastic Syndromes 132Hematologic Neoplasms 115Waldenstrom Macroglobulinemia 103Lymphoma, T-Cell, Peripheral 85Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 81Lymphoma, T-Cell 81Lymphoma, T-Cell, Cutaneous 66Leukemia, Myelogenous, Chronic, BCR-ABL Positive 62Mycosis Fungoides 57Leukemia, Biphenotypic, Acute 54Breast Neoplasms 54Myeloproliferative Disorders 50Leukemia, B-Cell 50Lymphoproliferative Disorders 47

Interventions

Ultrasonic Waves 1Tirzepatide 1Therapeutics 1Standard of Care 1Educational Status 1Dosage Forms 1Buprenorphine, Naloxone Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Opioid-Related Disorders × Lymphoid × 1 year × Clear all
NCT06651177 2026-05-22

TAB

University of Cincinnati

Phase 2 Recruiting
310 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT07451197 2026-05-11

Family-Focused Study to Support Medication for Opioid Use Disorder

University of Wisconsin, Madison

Phase NA Not yet recruiting
338 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT04921787 2026-04-23

EXHITENTRE

Hennepin Healthcare Research Institute

Phase NA Active not recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

NCT04091009 2025-12-31

Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms

Massachusetts General Hospital

Phase 4 Withdrawn
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT04345718 2025-12-09

EXHITENTRE

Hennepin Healthcare Research Institute

Phase 2/3 Completed
344 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡